President, Chief Executive Officer and Director · Harpoon Therapeutics, Inc. (HARP)

Julie Eastland

A named executive officer of Harpoon Therapeutics in every fiscal year CompBrief holds from FY2021 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$1,160,774

Salary $565,000Stock awards $250,000Bonus $62,150

FY2021: $2,227,341

2nd of 5 named executive officers at Harpoon Therapeutics by FY2022 total.

5 named officers on file for Harpoon Therapeutics, FY2022

Julie Eastland’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Harpoon Therapeutics’s whole pay program stands against its peers

  • Harpoon Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on HARP→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2023 (DEF 14A).

Free

Get Julie Eastland’s full pay file as a PDF — free

More than this page: up to 10 years of Julie’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Julie Eastland compensation by year

Harpoon Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Harpoon Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022
Salary$83,766$565,000
Bonus$205,000$62,150
Stock awards$0$250,000
Option awards$1,887,676$0
Non-equity incentive$0$217,525
Pension and deferred compensation$0$0
All other$50,899$66,099
Total$2,227,341$1,160,774

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Harpoon Therapeutics, Inc. DEF 14A filed April 27, 2023, accession 0001193125-23-122195, and prior-year filings.

How this page was built: the Harpoon Therapeutics, Inc. filed document, accession 0001193125-23-122195. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2023.

$2.2M
$1.2M
FY21
FY22
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
PSU375,000$272,250—
Option255,209—$6.85

Per the Outstanding Equity Awards at Fiscal Year-End table in Harpoon Therapeutics, Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Harpoon Therapeutics’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Holger WescheFormer Chief Science Officer (10)$1,432,904
Julie Eastland · this pagePresident, Chief Executive Officer and Director$1,160,774
Natalie SacksFormer Chief Medical Officer (9)$757,280
Georgia ErbezFormer Chief Financial Officer (8)$727,847
Luke WalkerChief Medical Officer (7)$668,964

The full Harpoon Therapeutics compensation record

free company brief

This page is one person within Harpoon Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Harpoon Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Julie Eastland's compensation dossier · One-time report. No refunds.